Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice
dc.contributor.author | Yoldaş İlktaç, Havvanur | |
dc.contributor.author | Kızıltan, Gül | |
dc.contributor.author | Lanpir, Aslı Devrim | |
dc.contributor.author | Ozansoy, Mehmet | |
dc.contributor.author | Günal, Mehmet Yalçın | |
dc.contributor.author | Özmen Togay, Sine | |
dc.contributor.author | Keskin, İlknur | |
dc.contributor.author | Özdemir, Ekrem M. | |
dc.contributor.author | Kılıç, Ulkan | |
dc.date.accessioned | 2022-09-12T10:30:40Z | |
dc.date.available | 2022-09-12T10:30:40Z | |
dc.date.issued | 2022 | |
dc.department | ALKÜ, Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | |
dc.description.abstract | We published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused | |
dc.identifier.doi | 10.3409/fb_70-1.05 | |
dc.identifier.endpage | 43 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 43 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12868/1557 | |
dc.identifier.uri | https://www.webofscience.com/wos/woscc/full-record/WOS:000713193000004 | |
dc.identifier.volume | 70 | en_US |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | |
dc.relation.ispartof | Folia Biologica-Krakow | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Cytokines | |
dc.subject | Probiotic | |
dc.subject | Omega-3 fatty acid | |
dc.subject | Inflammatory bowel diseases | |
dc.subject | Colitis | |
dc.title | Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Corrigendum to Combined Therapy with Probiotic VSL#3 and Omega-3 Fatty Acids Attenuates Colonic Injury and Inflammation in Chronic DNBS-induced Colitis in Mice.pdf
- Boyut:
- 43.75 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam metin / Full text
Lisans paketi
1 - 1 / 1
[ X ]
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: